Grants and Contributions:

Back to search
Agreement Number:
-
Agreement Value:
$366,920.00
Agreement Date:
Oct 1, 2014 - Mar 31, 2018
Description:
Exenatide and Insulin Glargine Combination Therapy for the Preservation of Pancreatic Beta-cell Function in Early Type 2 Diabetes: A Randomized Controlled Trial
Organization:
Canadian Institutes of Health Research
Location:
Toronto, Ontario, CA M5G 1X5
Reference Number:
236-2014-2015-Q2-00093
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:

Grant or Award spanning more than one fiscal year.
(2014-15 to 2017-18)

Recipient's Legal Name:
RETNAKARAN, Ravi R
Research Organization:
Sinai Health System (Toronto)